Operations Accounting Manager jobs in United States
cer-icon
Apply on Employer Site
company-logo

Integrated DNA Technologies · 4 days ago

Operations Accounting Manager

Integrated DNA Technologies (IDT) is a leading company in life sciences and biotechnology committed to innovation. The Operations Accounting Manager will oversee month-end close operations, strengthen internal controls, manage inventory valuation, and govern the fixed asset lifecycle while partnering with Engineering and Operations on capital projects.

BiotechnologyGeneticsHealth CareMedical

Responsibilities

Oversee operations-related month-end close: journal entries, reconciliations, accruals for COGS, inventory and fixed assets
Strengthen internal controls & support audits: cost accounting processes, fixed asset governance, inventory controls, and segregation of duties across ERP
Own the standard cost model and annual cost roll, including BOM/routing validation, labor and overhead rates, and burden allocation methodologies
Manage inventory valuation and integrity across raw/WIP/finished goods as well as monitoring slow/no-move & excess/obsolete reserves
Oversee costing controls and compliance: cycle counts, physical inventories, standard cost updates
Govern the fixed asset lifecycle: project creation, capitalization criteria, useful lives, depreciation methods, and retirements/disposals
Partner with Engineering/Operations to manage capital projects: budgeting, approvals, in‑process (AUC) tracking, and timely capitalization

Qualification

Cost accountingInventory managementFinancial analysisAdvanced ExcelLeadership experienceCPA

Required

High School degree with 8+ Years experience OR Bachelor's degree in Finance, Accounting related field with 5+ years experience OR Master's degree in field with 3+ years experience
Leadership experience
Advanced knowledge of Excel

Preferred

CPA

Benefits

Paid time off
Medical/dental/vision insurance
401(k)

Company

Integrated DNA Technologies

company-logo
Integrated DNA Technologies sells short strands of DNA called oligonucleotides.

Funding

Current Stage
Late Stage
Total Funding
unknown
2018-03-09Acquired
2014-03-19Private Equity

Leadership Team

leader-logo
Erik Swenson
Vice President, Chief Financial Officer
linkedin
leader-logo
Mark Behlke
Chief Scientific Officer
linkedin
Company data provided by crunchbase